The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis

被引:40
|
作者
Weamer, Elise A. [1 ,2 ]
Emanuel, James E. [1 ]
Varon, Daniel [1 ]
Miyahara, Sachiko [3 ]
Wilkosz, Patricia A. [1 ]
Lopez, Oscar L. [1 ,2 ]
DeKosky, Steven T. [1 ]
Sweet, Robert A. [1 ,2 ,4 ]
机构
[1] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA USA
[4] VA Pittsburgh Healthcare Syst, VISN Mental Illness Res Educ & Clin Ctr 4, Pittsburgh, PA USA
关键词
Alzheimer's disease; MCI (mild cognitive impairment); psychosis; cognitive neuropsychology in dementia; assessment of cognitive disorders/dementia; INCREASED FAMILIAL RISK; LAST; 2; DECADES; RATING-SCALE; MOUSE MODELS; SYMPTOMS; DELUSIONS; DIAGNOSIS; DEMENTIA; SCHIZOPHRENIA; HALLUCINATIONS;
D O I
10.1017/S1041610208007734
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Psychotic symptoms in Alzheimer disease (AD + P) identify a heritable phenotype associated with greater cognitive impairment. Knowing when the cognitive course of AD + P subjects diverges from that of subjects without psychosis would enhance understanding of how genetic variation results in AD + P and its associated cognitive burden. This study seeks to determine whether the degree of cognitive impairment and cognitive decline in early AD predicts subsequent AD + P onset. Methods: 361 subjects with possible or probable AD or mild cognitive impairment (MCI) without psychosis were evaluated every 6 months until psychosis onset. Results: Severity of cognitive dysfunction was a strong predictor of AD + P up to two years prior to psychosis onset. Cognition did not decline more rapidly prior to onset of AD + P. Conclusions: Individuals who will develop AD + P already demonstrate excess cognitive impairment during the mild stages of disease. Genetic variation and brain pathophysiology may lead to a cognitive risk phenotype which is present prior to dementia onset.
引用
收藏
页码:78 / 85
页数:8
相关论文
共 50 条
  • [21] Late-Life Depression, Cognitive Impairment, and Relationship with Alzheimer's Disease
    Invernizzi, Sandra
    Simoes Loureiro, Isabelle
    Kandana Arachchige, Kendra G.
    Lefebvre, Laurent
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2022, 50 (05) : 414 - 424
  • [22] Mild Cognitive Impairment (MCI) - The Novel Trend of Targeting Alzheimer's Disease in Its Early Stages - Methodological Considerations
    Pater, C.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (07) : 798 - 807
  • [23] Smell identification function in early-onset Alzheimer's disease and mild cognitive impairment
    Velayudhan, Latha
    Wilson-Morkeh, Frances
    Penney, Emily
    Jesu, Amala Jovia Maria
    Baillon, Sarah
    Brugha, Traolach
    INTERNATIONAL PSYCHOGERIATRICS, 2019, 31 (07) : 1065 - 1070
  • [24] Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer's disease
    Thomas, Alan J.
    Hamilton, Calum A.
    Barker, Sally
    Durcan, Rory
    Lawley, Sarah
    Barnett, Nicola
    Firbank, Michael
    Roberts, Gemma
    Allan, Louise M.
    O'Brien, John
    Taylor, John-Paul
    Donaghy, Paul C.
    INTERNATIONAL PSYCHOGERIATRICS, 2022, 34 (06) : 585 - 592
  • [25] Genetic associations with psychosis and affective disturbance in Alzheimer's disease
    Antonsdottir, Inga Margret
    Creese, Byron
    Klei, Lambertus
    DeMichele-Sweet, Mary Ann A.
    Weamer, Elise A.
    Garcia-Gonzalez, Pablo
    Marquie, Marta
    Boada, Merce
    Alarcon-Martin, Emilio
    Valero, Sergi
    Liu, Yushi
    Hooli, Basavaraj
    Aarsland, Dag
    Selbaek, Geir
    Bergh, Sverre
    Rongve, Arvid
    Saltvedt, Ingvild
    Skjellegrind, Havard K.
    Engdahl, Bo
    Andreassen, Ole A.
    Borroni, Barbara
    Mecocci, Patrizia
    Wedatilake, Yehani
    Mayeux, Richard
    Foroud, Tatiana
    Ruiz, Agustin
    Lopez, Oscar L.
    Kamboh, M. Ilyas
    Ballard, Clive
    Devlin, Bernie
    Lyketsos, Constantine
    Sweet, Robert A.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (02)
  • [26] Nutraceuticals in cognitive impairment and Alzheimer's disease
    Mecocci, P.
    Tinarelli, C.
    Schulz, R. J.
    Polidori, M. C.
    FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [27] Psychosis in Alzheimer’s Disease: a Review of Recent Research Findings
    Fischer C.E.
    Sweet R.A.
    Current Behavioral Neuroscience Reports, 2016, 3 (4) : 308 - 317
  • [28] Reduced parahippocampal volume and psychosis symptoms in Alzheimer's disease
    McLachlan, Emma
    Bousfield, Jennifer
    Howard, Robert
    Reeves, Suzanne
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (02) : 389 - 395
  • [29] Psychosis in Alzheimer's Disease is Associated with Frontal Metabolic Impairment and Accelerated Decline in Working Memory: Findings from the Alzheimer's Disease Neuroimaging Initiative
    Koppel, Jeremy
    Sunday, Suzanne
    Goldberg, Terry E.
    Davies, Peter
    Christen, Erica
    Greenwald, Blaine S.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 22 (07) : 698 - 707
  • [30] Trajectories of cognitive decline in Alzheimer's disease
    Wilkosz, Patricia A.
    Seltman, Howard J.
    Devlin, Bernie
    Weamer, Elise A.
    Lopez, Oscar L.
    DeKosky, Steven T.
    Sweet, Robert A.
    INTERNATIONAL PSYCHOGERIATRICS, 2010, 22 (02) : 281 - 290